title: [Cohorts and registers: Which public/private partnerships to choose?].
authors.affiliation: LEEM, 88, rue de Faisanderie, 75116 Paris, France. cjouan-flahault@leem.org
authors.forename: Chrystel
authors.initials: C
authors.lastname: Jouan-Flahault
authors.forename: Paul
authors.initials: P
authors.lastname: Landais
authors.forename: René
authors.initials: R
authors.lastname: Thomas
authors.forename: Samantha
authors.initials: S
authors.lastname: Parker
authors.forename: Delphine
authors.initials: D
authors.lastname: Genevaz
mesh_terms: D002755:Choice Behavior / Q000502:physiology; D002986:Clinical Trials as Topic / Q000191:economics; D015331:Cohort Studies; D003132:Commerce; D055808:Drug Discovery / Q000191:economics / Q000379:methods / Q000458:organization & administration; D004345:Drug Industry / Q000191:economics / Q000379:methods / Q000458:organization & administration; D005060:Europe; D006527:Hepatolenticular Degeneration / Q000209:etiology / Q000628:therapy; D006801:Humans; D009965:Orphan Drug Production / Q000191:economics / Q000379:methods; D055818:Public-Private Sector Partnerships / Q000706:statistics & numerical data*; D035583:Rare Diseases / Q000191:economics / Q000628:therapy*; D012042:Registries